Trial Profile
A study to evaluate the safety and efficacy of tolvaptan in acute heart failure with hypoalbuminemia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Oct 2015
Price :
$35
*
At a glance
- Drugs Tolvaptan (Primary)
- Indications Acute heart failure; Cardiac oedema
- Focus Therapeutic Use
- 29 Mar 2013 New trial record